bioRxiv / medRxivopen access
Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
dermatology
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 151575
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.